(Q34236472)

31 July 2017

title

Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease (English)

1 reference

31 July 2017

main subject

coronary artery disease

1 reference

5

1 reference

31 July 2017

4

Barbara Burwinkel

0 references

Dietrich Rothenbacher

3

object named as

Dietrich Rothenbacher

1 reference

31 July 2017

Lutz Philipp Breitling

1

object named as

Lutz Philipp Breitling

0 references

author name string

Lutz Philipp Breitling

1

1 reference

31 July 2017

Katrin Salzmann

2

1 reference

31 July 2017

publication date

17 April 2012

1 reference

31 July 2017

published in

European Heart Journal

1 reference

31 July 2017

volume

33

1 reference

31 July 2017

issue

22

1 reference

31 July 2017

page(s)

2841-2848

1 reference

How to prevent 100 million deaths from tobacco

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Shape of the relapse curve and long-term abstinence among untreated smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Epigenetics and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Tobacco-smoking-related differential DNA methylation: 27K discovery and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Protease-activated receptors in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Prognostic value of chronic kidney disease in patients with coronary heart disease: role of estimating equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Cholesteryl ester transfer protein in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

The future of biomarkers in the management of patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

The hemostatic system as a modulator of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Genome-scale approaches to the epigenetics of common human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Prognostic Usefulness of Free Fatty Acids in Patients With Stable Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS091

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHS091

1 reference

31 July 2017

1 reference